Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2005 2
2006 2
2007 3
2008 7
2009 4
2010 3
2011 2
2013 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
Drug targeting of dysregulated transcription in Huntington's disease.
Kazantsev AG, Hersch SM. Kazantsev AG, et al. Prog Neurobiol. 2007 Nov;83(4):249-59. doi: 10.1016/j.pneurobio.2007.02.005. Epub 2007 Feb 23. Prog Neurobiol. 2007. PMID: 17379386 Free PMC article. Review.
Complexity and heterogeneity: what drives the ever-changing brain in Huntington's disease?
Rosas HD, Salat DH, Lee SY, Zaleta AK, Hevelone N, Hersch SM. Rosas HD, et al. Ann N Y Acad Sci. 2008 Dec;1147:196-205. doi: 10.1196/annals.1427.034. Ann N Y Acad Sci. 2008. PMID: 19076442 Free PMC article. Review.
Mouse models of Huntington's disease and methodological considerations for therapeutic trials.
Ferrante RJ. Ferrante RJ. Biochim Biophys Acta. 2009 Jun;1792(6):506-20. doi: 10.1016/j.bbadis.2009.04.001. Epub 2009 Apr 10. Biochim Biophys Acta. 2009. PMID: 19362590 Free PMC article. Review.
Translating therapies for Huntington's disease from genetic animal models to clinical trials.
Hersch SM, Ferrante RJ. Hersch SM, et al. NeuroRx. 2004 Jul;1(3):298-306. doi: 10.1602/neurorx.1.3.298. NeuroRx. 2004. PMID: 15717031 Free PMC article. Review.
Neuroprotection for Huntington's disease: ready, set, slow.
Hersch SM, Rosas HD. Hersch SM, et al. Neurotherapeutics. 2008 Apr;5(2):226-36. doi: 10.1016/j.nurt.2008.01.003. Neurotherapeutics. 2008. PMID: 18394565 Free PMC article. Review.
Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration.
Sleiman SF, Langley BC, Basso M, Berlin J, Xia L, Payappilly JB, Kharel MK, Guo H, Marsh JL, Thompson LM, Mahishi L, Ahuja P, MacLellan WR, Geschwind DH, Coppola G, Rohr J, Ratan RR. Sleiman SF, et al. J Neurosci. 2011 May 4;31(18):6858-70. doi: 10.1523/JNEUROSCI.0710-11.2011. J Neurosci. 2011. PMID: 21543616 Free PMC article.
Mechanisms of copper ion mediated Huntington's disease progression.
Fox JH, Kama JA, Lieberman G, Chopra R, Dorsey K, Chopra V, Volitakis I, Cherny RA, Bush AI, Hersch S. Fox JH, et al. PLoS One. 2007 Mar 28;2(3):e334. doi: 10.1371/journal.pone.0000334. PLoS One. 2007. PMID: 17396163 Free PMC article.
Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse.
Hu Y, Chopra V, Chopra R, Locascio JJ, Liao Z, Ding H, Zheng B, Matson WR, Ferrante RJ, Rosas HD, Hersch SM, Scherzer CR. Hu Y, et al. Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):17141-6. doi: 10.1073/pnas.1104409108. Epub 2011 Oct 3. Proc Natl Acad Sci U S A. 2011. PMID: 21969577 Free PMC article. Clinical Trial.
Altered histone monoubiquitylation mediated by mutant huntingtin induces transcriptional dysregulation.
Kim MO, Chawla P, Overland RP, Xia E, Sadri-Vakili G, Cha JH. Kim MO, et al. J Neurosci. 2008 Apr 9;28(15):3947-57. doi: 10.1523/JNEUROSCI.5667-07.2008. J Neurosci. 2008. PMID: 18400894 Free PMC article.
Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity.
Rosas HD, Salat DH, Lee SY, Zaleta AK, Pappu V, Fischl B, Greve D, Hevelone N, Hersch SM. Rosas HD, et al. Brain. 2008 Apr;131(Pt 4):1057-68. doi: 10.1093/brain/awn025. Epub 2008 Mar 12. Brain. 2008. PMID: 18337273 Free PMC article.
28 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback